Genome-Editing Technologies in Adoptive T Cell Immunotherapy for Cancer

被引：0

作者：

Nathan Singh

Junwei Shi

Carl H. June

Marco Ruella

机构：

[1] Perelman School of Medicine at the University of Pennsylvania,Center for Cellular Immunotherapies

[2] University of Pennsylvania,Division of Hematology and Oncology

[3] University of Pennsylvania,Abramson Cancer Center

[4] Perelman School of Medicine at the University of Pennsylvania,Department of Pathology and Laboratory Medicine

[5] University of Pennsylvania,Parker Institute for Cancer Immunotherapy

来源：

Current Hematologic Malignancy Reports | 2017年 / 12卷

关键词：

CRISPR-Cas9; TALEN; Zinc-finger nucleases; Adoptive cell therapy; Chimeric antigen receptor T cells (CART); Immunotherapy; PD-1; Gene-editing;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：522 / 529

页数：7

共 243 条

[21]

Kolb HJ(2013)Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity Cell 154 1380-1512

[22]

Mittermuller J(2013)Genome engineering using the CRISPR-Cas9 system Nat Protoc 8 2281-148

[23]

Clemm C(2013)Multiplex genome engineering using CRISPR/Cas systems Science 339 819-405

[24]

Holler E(2005)Highly efficient endogenous human gene correction using designed zinc-finger nucleases Nature 435 646-338

[25]

Ledderose G(2008)Progress and prospects: zinc-finger nucleases as gene therapy agents Gene Ther 15 1463-826

[26]

Brehm G(2003)Chimeric nucleases stimulate gene targeting in human cells Science 300 763-5705

[27]

Higano CS(2009)Breaking the code of DNA binding specificity of TAL-type III effectors Science 326 1509-3864

[28]

Brixey M(2011)A TALE nuclease architecture for efficient genome editing Nat Biotechnol 29 143-2266

[29]

Bryant EM(2013)ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering Trends Biotechnol 31 397-117

[30]

Durnam DM(2012)RNA-guided genetic silencing systems in bacteria and archaea Nature 482 331-1349